Table 3.
Routine haematological parameters
| Parameter | Placebo | CLA | P value | |||
|---|---|---|---|---|---|---|
| Start | End | Start | End | gra | gr × tib | |
| Cholesterol (mmol/L) | 4.48 ± 0.66 | 4.39 ± 0.78 | 4.32 ± 0.76 | 4.29 ± 0.77 | 0.641 | 0.779 |
| TAG (mmol/L) | 1.28 ± 0.69 | 1.29 ± 0.96 | 0.90 ± 0.60 | 0.92 ± 0.55 | 0.043 | 0.494 |
| Creatinine (mmol/L) | 66.3 ± 11.6 | 64.4 ± 9.3 | 62.3 ± 5.5 | 63.9 ± 7.9 | 0.484 | 0.103 |
| ASAT (μmol/L × s) | 0.49 ± 0.11 | 0.44 ± 0.09 | 0.49 ± 0.07 | 0.48 ± 0.08 | 0.562 | 0.186 |
| ALAT (μmol/L × s) | 0.56 ± 0.13 | 0.55 ± 0.22 | 0.53 ± 0.10 | 0.49 ± 0.09 | 0.885 | 0.291 |
Data are expressed as means ± SD; astudy group (placebo/CLA), bstudy group (placebo/CLA) × study time point (start/end); ALAT – alanine aminotransferase, ASAT – aspartate aminotransferase, TAG – triacylglycerol